5. ENTECAVIR (Baraclude®)
{"Image DocumentName": "5. ENTECAVIR (Baraclude\u00ae)", "Image ImageDescription": "analogue structural de la guanosine nucl\u00e9oside , inhibe l\u2019ADN polym\u00e9rase. efficacit\u00e9 sup\u00e9rieure \u00e0 la lamivudine. efficace chez les malades AgHBe+ et AgHBe- moins efficace si virus r\u00e9sistant \u00e0 la lamivudine. posologie PO: 0,5 mg/J pour les malades naifs. 1 mg/J pour les malades ayant d\u00e9velopp\u00e9 une r\u00e9sistance \u00e0 la lamivudine. mol\u00e9cule bien tol\u00e9r\u00e9e. Risque d\u2019\u00e9mergence d\u2019une r\u00e9sistance du VHB \u00e0 l\u2019ent\u00e9cavir ?", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}